Thomas A. Mccourt - 06 Mar 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Director
Signature
/s/Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
06 Mar 2023
Net transactions value
$0
Form type
4
Filing time
08 Mar 2023, 15:42:42 UTC
Previous filing
07 Mar 2023
Next filing
10 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (Right to Buy) Award $0 +22,000 $0.000000 22,000 06 Mar 2023 Common Stock 22,000 $31.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 6, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.